Liberset
Overview
Liberset is a transatlantic investment firm focused on accelerating the growth of innovative companies fostering sustainable industrialization. With offices in the United States and Europe, Liberset invests in companies developing breakthrough solutions that address global industrial inefficiencies and promote decarbonization. Their investor base includes family-owned groups, family offices, experienced CEOs, and entrepreneurs from sectors such as farming, food, cosmetics, chemistry, energy, logistics, and construction. The firm's investment strategy centers on three strategic verticals: New Consumption, Clean Technologies, and Better Cities. They make growth equity and late-stage investments, typically ranging from $2 million to $10 million per company over the course of a lifecycle. Liberset focuses on minority equity with governance influence and also engages in indirect investments in impact funds to diversify risks and optimize deal flow. Liberset's portfolio includes companies like Novolyze, Qualisteo, Weenat, Abolis Biotechnologies, and ORIS Materials Intelligence. Their mission is to support the transatlantic expansion of these portfolio companies while fostering global sustainable value creation, leveraging a robust community of investors committed to responsible governance and long-term value creation.
Investment Focus
- Companies developing breakthrough solutions addressing global industrial inefficiencies
- Focus on sustainable manufacturing and decarbonization
- Alignment with New Consumption, Clean Technologies, or Better Cities verticals
- Potential for transatlantic expansion
- Strong governance and management teams
Portfolio Companies
Reach Liberset directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Liberset
What sectors does Liberset invest in?
Liberset invests in Technology, Energy, Infrastructure, Materials, Agriculture and Logistics, and is based in Florida, United States. Liberset is listed as a private equity in the ConnectSafely investor database.
What stage does Liberset invest at?
Liberset backs companies at Growth, Late Stage and Pre-IPO, writing cheques of 2M - 10M.
Which regions does Liberset invest in?
Liberset invests across United States, United Kingdom, Germany, France, Italy and Denmark.
Who are the partners at Liberset?
Team members listed for Liberset include Cyrille Pauthenier (FOUNDER & CEO – ABOLIS BIOTECHNOLOGIES) and Jean-Louis Lelogeais (FOUNDING PARTNER & Co-Founder – PEO PARTNERS).
What companies has Liberset invested in?
Liberset's portfolio includes Weenat, Novolyze, Qualisteo, Abolis Biotechnologies and ORIS Materials Intelligence.
How do I contact Liberset?
Liberset's contact details — including phone and LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database
